Canada DNA Diagnostics Market Size & Outlook, 2030

Revenue, 2024 (US$M)

$0.0

Forecast, 2030 (US$M)

$0.0

CAGR, 2025 - 2030

Report Coverage

Canada

Canada dna diagnostics market, 2018-2030 (US$M)

Related Markets

Global DNA Diagnostics Industry Outlook

North America DNA Diagnostics Market Outlook

Europe DNA Diagnostics Market Outlook

Asia Pacific DNA Diagnostics Market Outlook

Latin America DNA Diagnostics Market Outlook

MEA DNA Diagnostics Market Outlook

Canada dna diagnostics market highlights

The Canada dna diagnostics market generated a revenue of USD 943.6 million in 2023 and is expected to reach USD 1,319.0 million by 2030.
The Canada market is expected to grow at a CAGR of 4.9% from 2024 to 2030.
In terms of segment, pcr-based diagnostics was the largest revenue generating technology in 2023.
NGS DNA Diagnosis is the most lucrative technology segment registering the fastest growth during the forecast period.

Dna diagnostics market data book summary

Market revenue in 2023	USD 943.6 million
Market revenue in 2030	USD 1,319.0 million
Growth rate	4.9% (CAGR from 2023 to 2030)
Largest segment	Pcr-based diagnostics
Fastest growing segment	NGS DNA Diagnosis
Historical data	2018 - 2022
Base year	2023
Forecast period	2024 - 2030
Quantitative units	Revenue in USD million
Market segmentation	PCR-based Diagnostics, NGS DNA Diagnosis, In-Situ Hybridization Diagnostics, Microarrays-based Diagnostics
Key market players worldwide	GE HealthCare Technologies Inc Common Stock, Abbott Laboratories, Beckman Coulter, Bio-Rad Laboratories Inc, Thermo Fisher Scientific Inc, Illumina Inc, Danaher Corp, Hologic Inc, Siemens Healthineers AG ADR, Roche, Qiagen NV, Agilent Technologies Inc

Other key industry trends

In terms of revenue, Canada accounted for 8.9% of the global dna diagnostics market in 2023.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
In North America, U.S. dna diagnostics market is projected to lead the regional market in terms of revenue in 2030.
Canada is the fastest growing regional market in North America and is projected to reach USD 1,319.0 million by 2030.

Key Regions: U.S. , UK , Japan , Brazil , Germany

No credit card required*

Horizon in a snapshot

30K+ Global Market Reports
120K+ Country Reports
1.2M+ Market Statistics
200K+ Company Profiles
Industry insights and more

DNA Diagnostics Market Scope

Dna diagnostics market segmentation & scope

Technology

PCR-based Diagnostics

NGS DNA Diagnosis

In-Situ Hybridization Diagnostics

Microarrays-based Diagnostics

Application

Cancer Genetics Tests

Infectious Diseases DNA Testing

HBV Diagnostic

HCV Diagnostic

HIV Diagnostic

TB Diagnostic

CT/NG Diagnostic

HPV Diagnostic

MRSA Diagnostic

Others Infectious Disease Diagnostic

Newborn Genetic Screening

Preimplantation & Reproductive Diagnosis

Non-Infectious Diseases DNA Testing

Cardiovascular Diseases

CNS & PNS Related

Skeletal, Connective, Ectodermal & Dermal DNA Testing

Lung, Kidney, Liver & GT Related

Sensory Diseases

Prenatal DNA Carrier Screening

Pharmacogenomics/Drug Metabolism

Hematology & Immunology/Identity Diagnostics & Forensics

Other Applications

Regions

Latin America

Europe

North America

Middle East & Africa

Asia Pacific

Countries

U.S.

Canada

Mexico

Germany

Spain

France

Italy

Denmark

Sweden

Norway

Japan

China

India

South Korea

Australia

Thailand

Brazil

Argentina

South Africa

Saudi Arabia

UAE

Kuwait

DNA Diagnostics Market Companies

Name	Profile	# Employees	HQ	Website

Canada dna diagnostics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dna diagnostics market will help companies and investors design strategic landscapes.

Pcr-based diagnostics was the largest segment with a revenue share of 49.88% in 2024. Horizon Databook has segmented the Canada dna diagnostics market based on pcr-based diagnostics, ngs dna diagnosis, in-situ hybridization diagnostics, microarrays-based diagnostics covering the revenue growth of each sub-segment from 2018 to 2030.

The market in Canada is expected to grow at a lucrative rate over the forecast period. It follows the U.S. in adopting diagnostic tests, as FDA-approved tests are permitted in the country. The presence of microbiology facilities in the country is expected to drive the DNA diagnostics market growth.

For instance, the National Microbiology Laboratory (NML) in Canada is renowned for its exceptional level of scientific research worldwide. Organizations collaborate with international and Canadian public health partners to prevent the spread of transmissible diseases.

Laboratories’ primary functions include research, lab-based surveillance, and specialized services to identify diseases that other labs may not be able to detect or diagnose, among others. A group of local community representatives make up the Community Liaison Committee (CLC), which is a subsidiary body of the Canadian Science Centre for Human and Animal Health (CSCHAH).

Reasons to subscribe to Canada dna diagnostics market databook:

Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Canada dna diagnostics market databook

Our clientele includes a mix of dna diagnostics market companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Canada dna diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Canada dna diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list